Abstract 3632: BiTE® antibody constructs for the treatment of SCLC
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-3632
Abstract: Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor with a poor prognosis and limited therapeutic options. Most patients present with extensive stage disease, where recent advances in immunotherapies, including bi-specific T cell… read more here.
Keywords: bite antibody; sclc; antibody; antibody constructs ... See more keywords